| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$41 |
Final Director's Interest Notice - SH
|
28 Apr 2025 12:33PM |
$0.220 |
$0.160 |
fallen by
27.27%
|
|
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,466 |
Quarterly Results Presentation
|
28 Apr 2025 12:27PM |
$2.760 |
$3.730 |
risen by
35.14%
|
|
PNR - Price-sensitive ASX Announcement
Full Release
Key Points
- Production reduced slightly to 18,334 ounces due to Scotia Underground Mine ramp-up.
- OK Underground Mine produced 7,949 ounces, slightly lower than planned due to operator absences.
- Open pit mining at Princess Royal commenced in March 2025.
- Processing plant continued to operate at 1.2 million tpa with 305,800 tonnes processed.
- Debt significantly reduced to US$6.26 million after convertible note conversion.
- Share consolidation approved at a ratio of 1/17.
- Safety performance included one lost time injury and over 4,000 hazards reported.
- Exploration expenditure increased to $10.4 million in line with growth planning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeeris Ltd (AER) ORDINARY FULLY PAID |
Communication Services |
$6 |
New Technology Strengthens Insurance Industry Leadership
|
28 Apr 2025 12:26PM |
$0.056 |
$0.075 |
risen by
33.93%
|
|
| Richmond Vanadium Technology Limited (RVT) ORDINARY FULLY PAID |
Materials |
$35 |
Notification of cessation of securities - RVT
|
28 Apr 2025 12:25PM |
$0.160 |
$0.160 |
fallen by
0%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$198 |
Trading Halt
|
28 Apr 2025 12:22PM |
$0.300 |
$0.190 |
fallen by
36.67%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- betr Entertainment Limited requested a trading halt.
- The halt is pending an announcement regarding an accelerated entitlement offer.
- Trading will resume on 30 April 2025 unless ASX decides otherwise.
- The request for a halt complies with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Henderson Sustainable Credit Active ETF (Managed Fund) (GOOD) |
Financials |
$4 |
GOOD - April 2025 Distribution Estimate CPU
|
28 Apr 2025 12:15PM |
$51.220 |
$50.620 |
fallen by
1.17%
|
|
| BCAL Diagnostics Limited (BDX) ORDINARY FULLY PAID |
Health Care |
$33 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2025 12:13PM |
$0.084 |
$0.090 |
risen by
7.14%
|
|
BDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Commercial launch of BREASTEST plus achieved first revenues.
- Focus on expanding availability into additional clinics across Australia.
- Engaging breast specialists to support clinical adoption.
- Completed clinical validation and received NATA accreditation.
- Solid cash position with $5 million reported as of March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Supply Network Limited (SNL) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,416 |
Change of Director's Interest Notice
|
28 Apr 2025 12:11PM |
$37.860 |
$32.370 |
fallen by
14.50%
|
|
| Richmond Vanadium Technology Limited (RVT) ORDINARY FULLY PAID |
Materials |
$35 |
Results of the Minimum Holding Share Buy-Back
|
28 Apr 2025 12:10PM |
$0.160 |
$0.160 |
fallen by
0%
|
|
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$382 |
2025 Infill Drilling Operation in Block 22/12
|
28 Apr 2025 12:08PM |
$0.183 |
$0.235 |
risen by
28.77%
|
|
HZN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of 2025 infill drilling operation in Block 22/12.
- Drilling rig mobilized to the WZ12-8W platform.
- Well spud on 28 April 2025.
- Recovery from the well classified as contingent resources.
- Well expected to recover 0.4 million barrels gross.
- Horizon Oil's net share estimated at 0.1 million barrels.
- Targeted incremental oil rate of 500 bopd gross.
- CNOOC operating the drilling and completion operation.
- Operation expected to last approximately 30 days.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Charter Hall Group (CHC) STAPLED SECURITIES US PROHIBITED |
Real Estate |
$9,824 |
Ceasing to be a substantial holder from MUFG
|
28 Apr 2025 12:06PM |
$16.590 |
$20.770 |
risen by
25.20%
|
|
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
- |
Mar25 Appendix 4C Cash Flow Report
|
28 Apr 2025 12:06PM |
$0.025 |
$0.028 |
risen by
12%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Funding facility of up to $38.5 million from Clendon Biotech Capital.
- Facility covers clinical trial costs for IRX-211 and IRX-616a development.
- No amounts drawn down as of March 31, 2025.
- Initial drawdown of $247,500 occurred on April 24, 2025.
- Cash balance of $63,000 at quarter end.
- Net cash outflow from operating activities reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
- |
Mar25 Quarterly Activities Report
|
28 Apr 2025 12:06PM |
$0.025 |
$0.028 |
risen by
12%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- InhaleRx is developing two drugs, IRX-211 for breakthrough cancer pain and IRX-616a for panic disorder.
- IRX's clinical trial program will be among the first involving inhaled cannabinoid medications for pain and anxiety.
- The company completed a $38.5 million funding agreement with Clendon Biotech to accelerate drug development.
- The sample size for IRX-211's clinical trial was expanded to improve statistical significance.
- Manufacturing for trial drugs can commence following approval from the Human Research Ethics Committee.
- IRX-616a's Phase 1 trial for safety and tolerability in healthy volunteers has been planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$255 |
Quarterly Cashflow Report
|
28 Apr 2025 12:05PM |
$0.013 |
$0.031 |
risen by
138.46%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was a negative $2,732,000.
- Total exploration and evaluation expenditure for the quarter amounted to $1,820,000.
- Orion secured a $2 million unsecured convertible loan facility post quarter end.
- The IDC Convertible Loan balance was ZAR250 million at quarter end.
- Total financing facilities available at quarter end were $40,095,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$255 |
Quarterly Activities Report
|
28 Apr 2025 12:04PM |
$0.013 |
$0.031 |
risen by
138.46%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Finalisation and publication of the DFS for both PCZM and Flat Mines on 28 March 2025.
- PCZM study demonstrates robust financial metrics with a two-stage development strategy.
- Initial mining will focus on high-grade sulphide mineralisation within the +105m Block.
- Expected first bulk concentrate production from Upper Levels mining in 13 months.
- Health and safety incidents tracked with a Lost-Time Injury Frequency Rate of 0.78 for the year.
- Community engagement efforts include training programs for local participants.
- First production from the key development projects targeted for late 2026 or early 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tribeca Global Natural Resources Limited (TGF) ORDINARY FULLY PAID |
Financials |
$201 |
Estimated Weekly NTA as of 24 April 2025
|
28 Apr 2025 12:02PM |
$1.380 |
$2.730 |
risen by
97.83%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$393 |
Becoming a substantial holder from MUFG
|
28 Apr 2025 12:01PM |
$3.060 |
$2.090 |
fallen by
31.70%
|
|
| KMD Brands Limited (KMD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$80 |
Ongoing Disclosure Notice - Brent Scrimshaw
|
28 Apr 2025 12:00PM |
$0.310 |
$0.055 |
fallen by
82.26%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$75 |
Vitrafy Q3 FY25 Investor Briefing
|
28 Apr 2025 11:54AM |
$1.460 |
$1.860 |
risen by
27.40%
|
|
| AuKing Mining Limited (AKN) ORDINARY FULLY PAID |
Materials |
$41 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2025 11:53AM |
$0.007 |
$0.024 |
risen by
242.86%
|
|
AKN - Price-sensitive ASX Announcement
Full Release
Key Points
- AuKing focused on gold, uranium, copper, and niobium/REE projects.
- Plans for an airborne radiometric survey in Canada by mid-2025.
- Drilling program at Mkuju project to commence after the wet season.
- Joint venture in Saudi Arabia under negotiation.
- Strategic agreements aimed at enhancing financial stability.
- Reported cash reserves of $440,000 as of March 31, 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resimac Group Limited (RMC) ORDINARY FULLY PAID |
Financials |
$366 |
Notification of cessation of securities - RMC
|
28 Apr 2025 11:49AM |
$0.850 |
$0.925 |
risen by
8.82%
|
|
| Infinity Metals Limited (INF) ORDINARY FULLY PAID |
Materials |
$6 |
DTM: $3.4m Divestment of Non-Core Victorian Projects
|
28 Apr 2025 11:48AM |
$0.025 |
$0.013 |
fallen by
48%
|
|
INF - Price-sensitive ASX Announcement
Full Release
Key Points
- Dart Mining and Infinity Lithium entered into option agreements for project divestment.
- Projects include Mitta-Mitta and Corryong located in Victoria.
- The exclusivity period for Infinity is set at 60 days.
- Upfront consideration includes $475,000 in cash and shares.
- Total potential consideration could reach $3.4 million based on performance milestones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dart Mining NL (DTM) ORDINARY FULLY PAID |
Materials |
$7 |
$3.4m Divestment of Non-Core Victorian Projects
|
28 Apr 2025 11:48AM |
$0.005 |
$0.034 |
risen by
655.56%
|
|
DTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Dart Mining NL and Infinity Lithium Corporation Limited have entered into option agreements.
- The option agreements cover the Mitta-Mitta and Corryong projects.
- Total potential consideration is $3.4 million in cash and shares.
- Dart Mining will receive an upfront payment of $475,000 upon exercise of the options.
- The funds will support Dart Mining's exploration activities in Queensland and Victoria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bega Cheese Limited (BGA) ORDINARY FULLY PAID |
Consumer Staple |
$1,803 |
Fonterra Legal Proceedings Case Dismissed
|
28 Apr 2025 11:43AM |
$5.380 |
$5.900 |
risen by
9.67%
|
|
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$718 |
Distribution Details 30 April 2025
|
28 Apr 2025 11:41AM |
$1.025 |
$1.040 |
risen by
1.46%
|
|
Call 1300 880 160
Start a chat
Schedule a call
